Anti-HIV Agents

"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Descriptor ID	D019380
MeSH Number(s)	D27.505.954.122.388.077.088
Concept/Terms	Anti-HIV Agents Anti-HIV Agents Agents, Anti-HIV Anti HIV Agents Anti-AIDS Agents Agents, Anti-AIDS Anti AIDS Agents Anti-HIV Drugs Anti HIV Drugs Drugs, Anti-HIV AIDS Drugs Drugs, AIDS Anti-AIDS Drugs Anti AIDS Drugs Drugs, Anti-AIDS

Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]
Anti-Retroviral Agents [D27.505.954.122.388.077]
Anti-HIV Agents [D27.505.954.122.388.077.088]

Below are MeSH descriptors whose meaning is related to "Anti-HIV Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.

Bar chart showing 265 publications over 27 distinct years, with a maximum of 24 publications in 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
1998	1	1	2
2000	1	2	3
2001	1	3	4
2002	2	2	4
2003	5	2	7
2004	6	3	9
2005	1	5	6
2006	4	3	7
2007	8	4	12
2008	4	1	5
2009	2	1	3
2010	9	1	10
2011	5	3	8
2012	10	3	13
2013	9	6	15
2014	8	2	10
2015	13	3	16
2016	15	3	18
2017	20	4	24
2018	8	8	16
2019	8	5	13
2020	14	6	20
2021	14	5	19
2022	8	0	8
2023	6	0	6
2024	3	2	5

Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.

Robinson M, Aidoo-Frimpong G, Nelson L, Sandoval-Rosario M, Williams B, Chandler R. Navigating Pre-exposure Prophylaxis Access: Qualitative Insights From Black Women at a Northeastern Historically Black College and University. J Assoc Nurses AIDS Care. 2024 May-Jun 01; 35(3):234-244.

View in: PubMed
Trepka MJ, Gong Z, Ward MK, Fennie KP, Sheehan DM, Jean-Gilles M, Devieux J, Iba?ez GE, Gwanzura T, Nawfal ES, Gray A, Beach MC, Ladner R, Yoo C. Using Causal Bayesian Networks to Assess the Role of Patient-Centered Care and Psychosocial Factors on Durable HIV Viral Suppression. AIDS Behav. 2024 Jun; 28(6):2113-2130.

View in: PubMed
Maragh-Bass AC, Kiplagat S, Lavari S, Sastre F, Devieux JG, Jimenez D, Clarke RD, Noel I, Schrimshaw EW, Sevelius J, Cyrus E. Barriers to Accessing and Engaging in HIV Preventive Care and Pre-Exposure Prophylaxis Experienced by Transgender Women in Florida. Int J Environ Res Public Health. 2024 Mar 21; 21(3).

View in: PubMed
Deaterly C, Richards V, Weaver M, Villalba K, Varma D, Payton I, Cook R. Associations of Intimate Partner Violence and Drug Use on Viral Suppression Among Women Living With HIV in South Florida: A Secondary Analysis. J Assoc Nurses AIDS Care. 2024 May-Jun 01; 35(3):245-251.

View in: PubMed
Wyatt GE, Norwood-Scott E, Cooley-Strickland M, Zhang M, Smith-Clapham A, Jordan W, Liu H, Hamilton AB. Increasing Urban African American Women's Readiness for Pre-exposure Prophylaxis: A Pilot Study of the Women Prepping for PrEp Plus Program (WP3+). Womens Health Issues. 2024 May-Jun; 34(3):241-249.

View in: PubMed
Gray A, Ward MK, Fernandez SB, Nawfal ES, Gwanzura T, Li T, Sheehan DM, Jean-Gilles M, Beach MC, Ladner RA, Trepka MJ. Exploring the use of self-management strategies for antiretroviral therapy adherence among women with HIV in the Miami-Dade County Ryan White Program. J Behav Med. 2024 Apr; 47(2):282-294.

View in: PubMed
Del Pino HE, Rojas E, Dacus JD, Dur?n P, Mart?nez AJ, Hern?ndez JA, Ayala G, Zea MC, Schrode K, Harawa NT. Would the Siblings of Latinx Men Who Have Sex With Men Encourage Their Brothers to Use PrEP? Findings From a Feasibility and Acceptability Study. AIDS Educ Prev. 2023 10; 35(5):390-405.

View in: PubMed
Wells KJ, Gordon JR, Carrizosa CM, Mozo EH, Lucido NC, Cobian Aguilar RA, Brady JP, Rojas SA, Ramers CB, Nogg KA, Fahey KML, Jones IJ, Rivera DB, Blashill AJ. Interpersonal and Community-Level Influences Across the PrEP Cascade Among Young Adult Latinx Men who Have Sex with Men Living in a US-Mexico Border Region: A Qualitative Study. AIDS Behav. 2024 Mar; 28(3):759-773.

View in: PubMed
Gbadamosi SO, Boyce G, Trepka MJ, Edwards RJ. The Burden of Pretreatment HIV Drug Resistance in Trinidad and Tobago. AIDS Res Hum Retroviruses. 2024 04; 40(4):189-197.

View in: PubMed
Dorvil N, Rivera VR, Riviere C, Berman R, Severe P, Bang H, Lavoile K, Devieux JG, Faustin M, Saintyl G, Mendicuti MD, Pierre S, Apollon A, Dumond E, Forestal GPL, Rouzier V, Marcelin A, McNairy ML, Walsh KF, Dupnik K, Reif LK, Byrne AL, Bousleiman S, Orvis E, Joseph P, Cremieux PY, Pape JW, Koenig SP. Same-day testing with initiation of antiretroviral therapy or tuberculosis treatment versus standard care for persons presenting with tuberculosis symptoms at HIV diagnosis: A randomized open-label trial from Haiti. PLoS Med. 2023 06; 20(6):e1004246.

View in: PubMed

People

Explore

Similar Concepts

Top Journals